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COVID Briefs
Intellectual Disability a High
Risk for COVID-19 Death
Early in the COVID-19 pandemic,
researchers realized that people over
65 were more likely — 80 times more
likely — to die from a COVID-19 infection
than younger patients. As the pandemic
continued, other risk factors emerged:
underlying health conditions and
those from racial and ethnic minority
groups. Mary Stephens, MD, Wendy Ross,
MD, and colleagues were interested in
whether having an intellectual disability
might be a risk factor also. To find
out, they analyzed a massive dataset
of nearly 65 million patients infected
with COVID-19, in a study published
in NEJM Catalyst. Their analysis showed
that having an intellectual disability put
people at the highest risk for COVID-19
infection and second-highest risk for
death from the disease, after older
adults. As a result of the study, patients
with intellectual disabilities were
prioritized for vaccination.  ESZ

Collaborating across disciplines, doctors
and designers, textile experts and frontline
workers came together to come up with
solutions that could relieve the stress
put on the system. When there weren’t
enough ventilators for the patients who
needed them, they developed prototypes
for a computer-controlled ventilator
splitter. When surgical gowns became
more expensive to use, textile researchers
designed a better-fitting surgical gown
that simplified manufacture. When a
factory-issued part of the full-body PAPR
hazard suits kept breaking, a large team
came up with a 3-D printed alternative to
keep the suits in circulation.  ESZ

The Secret Sauce in
COVID-19 Vaccines
The first two COVID-19 vaccines in the
U.S. were a unique formulation: mRNA
strands packed inside of a nano-sized
layer of fat — a lipid nanoparticle. The
mRNA held instructions for making
the COVID-19 spike protein, and the
nanoparticles offered a convenient way
to fuse easily with the lipid covering
of our own cells. However, because the
vaccine wasn’t expected to cause all of
the inflammatory side effects — like fever,
chills and body aches — that it did, Botond
Igyártó, PhD, and team wondered whether
the lipid particles might be to blame. To
find out, they injected mice with the lipid
nanoparticles alone (no mRNA), and saw
massive inflammatory reactions. Their
work showed that the nanoparticles were
not just for mRNA delivery, but also could
have been responsible for jump-starting
the immune response, and giving some
of us those achy post-vaccine symptoms.

is particularly problematic for persons
with dementia, as social engagement is
often used to slow the progression of
dementia. Together with colleagues, Kristin
Rising, MD, and Angela Gerolamo, PhD,
interviewed patients with dementia and
their at-home caregivers about the most
challenging aspects of the COVID-19
pandemic. Respondents described how
prolonged isolation led to feelings of
loneliness, depression and worsening
memory problems. Caregivers felt a
heightened responsibility and burden for
care, and reported often putting their own
needs on hold. The work highlights the
need for healthcare providers to develop
and provide interventions and tools to
support families who care for people with
dementia.  ESZ

Predicting the Severe Cases
of COVID-19
One of the most unsettling facts of
COVID-19 is how difficult it is to predict
when the disease will turn deadly. For
some, there are only mild symptoms; for
others the disease can turn severe in a
rapid and unexpected manner. Colleagues
from the Department of Medicine and
Department of Surgery built a tool to
help clinicians predict those severe cases
that would require closer monitoring.
Using machine learning and clinical
experience, the investigators defined
a list of eight predictors that included
risk factors such as age, sex, diabetes or
labored breathing, together with clinical
measurements collected by blood test.
They used these input variables to create a
web-based tool that could be accessed at
the bedside on a phone or tablet.  ESZ

 ESZ

Design Solutions for
COVID-19 Problems
Jefferson’s focus on design thinking
and innovation paid dividends during
COVID-19, when hospitals, including
our own, were hit with shortages in
everything from hospital gowns and
full-body protective coverings, to masks
and childcare for essential workers.
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At Home with Dementia
during the Pandemic
Isolation, due to COVID-19, became
a necessity in the past two years,
especially for those 65 and older due to
their high mortality risk. But limiting
social interaction presents challenges
for maintaining mental wellbeing. It
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